Avansdose Pharmatech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 10.00 K
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 18.34%
- Profit Growth 39.71%
- Ebitda -28.84%
- Net Worth 76.11%
- Total Assets -11.27%
About Avansdose Pharmatech
Avansdose Pharmatech Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 February 2017 (Seven years and 11 months 11 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Ravindra Balwani and Gagan Singh serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TG2017PTC115497
-
Company No.
115497
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Feb 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Avansdose Pharmatech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindra Balwani
|
Director | 27-Feb-2017 | Current |
|
Gagan Singh
|
Director | 27-Feb-2017 | Current |
Financial Performance of Avansdose Pharmatech.
Avansdose Pharmatech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.34% increase. The company also saw a substantial improvement in profitability, with a 39.71% increase in profit. The company's net worth Soared by an impressive increase of 76.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avansdose Pharmatech?
Unlock access to Avansdose Pharmatech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Elevatoz Loyalty Private LimitedGagan Singh is a mutual person
-
Avanscure Lifesciences Private LimitedGagan Singh is a mutual person
-
Atomikon Sciences Private LimitedGagan Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avansdose Pharmatech?
Unlock and access historical data on people associated with Avansdose Pharmatech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avansdose Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avansdose Pharmatech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.